1KUNAPULI S P, DORSAM R T, KIM S, et al. Platelet purinergic receptors [ J ]. Curr Opin Pharmacol , 2003,3 (1) :175-180. 被引量：1
2WIVIOTT S D, ANTMAN E M. Clopidogrel resistance:a new chapter in a fastmoving story [ J ]. Circulation, 2004, 9( 13 ) :3064-3067. 被引量：1
3SLOTTOW T P, BONELLO L, GAVINI R, et al. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting atent thrombosis [ J]. Am J Cardiol,2009,104 ( 3 ) :525-530. 被引量：1
4SEREBRUANY V, CHERALA G, WOLLIAMS C, et al. Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance" [J]. Am Heart J, 2009,158(8) :925-932. 被引量：1
6TAUBERT D, KASTRATI A, HARLFINGER S, et al. Pharmacokinetics of clopidogrel after administration of a high loading dose [ J]. Thromb haemost, 2004, 92 ( 2 ) : 311 - 316. 被引量：1
7LAU W C, GURBEL P A, WATKINS P B, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J ]. Circulation, 2004,109 ( 2 ) : 166-171. 被引量：1
8SAW J, BRENNAN D M, STEINHUBL S R, et al. Lack of evidence of a clopidogrelstatin interaction in the CHARISMA trial[ J]. J Am Coll Cardiol , 2007,50 (2) : 291-295. 被引量：1
9HOP M, MADDOXT M, WANG L, et al. Risk ofadvoutcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[ J ]. JAMA ,2009,301 (6) :937-944. 被引量：1
10SILLER-MATULA J M, LANG I, CHRIST G, et al. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel [J]. J Am Coll Cardiol, 2008,52(10) : 1557- 1563. 被引量：1
